Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Sciclone G3 Liquid Handling Workstation

Product Image
Product Description

The Sciclone G3 workstation is Caliper’s highly flexible automated liquid handling workstation for drug discovery.  With proven performance, open-deck design, and integration-friendly architecture, Caliper's Sciclone G3 lab automation systems can be configured to handle just about any automated liquid handling application focus area including genomics, proteomics, immunoassays, and cell based assays.

The Sciclone G3, the latest iteration of Caliper's plate-prep workstation, features a 96- or 384-channel pipetting head, optional eight-channel pipettor and/or bulk reagent dispenser as well as Caliper's new "PING!" non-contact liquid level detection technology to ensure that all samples are processed during vacuum or pressure filtration. Sciclone also supports mag bead-based separations along with a large variety of on-deck shaking, heating and cooling options. The Sciclone G3T version with point-and-click capability supports up to 96 sample tubes with "smart" racks that ensure proper sample loading and identification prior to assay runs.

Applications:

• Next Generation Sequencing
• DNA Extraction
• Gene Expression
• HTS (High Throughput Screening)
• HCS (High Content Screening)
• Protein Purification
• DNA Purification
• DNA Isolation
• Genotyping
• ADME/ADMET
• GPCR
• RNA Extraction
• RNA Purification
• High-throughput plasmid preparation
• BAC DNA preparation
• Sequencing template amplification
• SNP genotyping
• High-throughput PCR cleanup

Product Sciclone G3 Liquid Handling Workstation
Company Caliper Life Sciences
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Caliper Life Sciences
68 Elm Street Hopkinton, MA 01748 USA

Tel: 1.508.435.9500
Fax: 1.508.435.3439



Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.

SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!